NRXS
NeurAxis, Inc.
NASDAQ · Healthcare · Biotechnology · US
$5.96
−1.81%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 19.23x
- P/S forward
- 5.89x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 11.11x
- Price / sales
- 14.08x
- Price / cash flow
- -13.32x
Enterprise value
- Enterprise value
- $66.8M
- EV / sales
- 12.57x
- EV / EBITDA
- -8.91x
- EV / EBIT
- -8.70x
- Market cap
- $74.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026